Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.34
-0.02 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
21.52
+0.18 (0.84%)
After-hours: Dec 5, 2025, 7:30 PM EST
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $2.09 billion as of December 5, 2025. Its market cap has increased by 102.53% in one year.
Market Cap
2.09B
Enterprise Value
2.04B
1-Year Change
102.53%
Ranking
Category
Stock Price
$21.34
Market Cap Chart
Since April 15, 2024, Avadel Pharmaceuticals's market cap has increased from $1.54B to $2.09B, an increase of 35.80%. That is a compound annual growth rate of 20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.09B | 106.62% |
| Dec 31, 2024 | 1.01B | -34.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 901.10B |
| Johnson & Johnson | 487.33B |
| AbbVie | 400.22B |
| UnitedHealth Group | 299.81B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.44B |
| Abbott Laboratories | 217.93B |